Breaking News Instant updates and real-time market news.

EFX

Equifax

$95.55

-3.4403 (-3.48%)

, AAPL

Apple

$159.65

-1.21 (-0.75%)

13:01
09/14/17
09/14
13:01
09/14/17
13:01

Equifax victims may struggled to buy new iPhone, AP reports

Apple (AAPL) users who froze their credit following the Equifax (EFX) data breach may have a mess on their hands if they attempt to buy one of the new iPhones that can cost over $1,000, the Associated Press reports. Anyone who opted to freeze their credit following the disclosure could experience issues when trying to finance a new phone, the report says. People can unfreeze their credit before a big purchase, though how long it will take and how much it costs vary state by state, the report notes. Reference Link

EFX

Equifax

$95.55

-3.4403 (-3.48%)

AAPL

Apple

$159.65

-1.21 (-0.75%)

  • 15

    Sep

EFX Equifax
$95.55

-3.4403 (-3.48%)

09/14/17
JPMS
09/14/17
NO CHANGE
Target $135
JPMS
Overweight
Equifax price target lowered to $135 from $167 at JPMorgan
JPMorgan analyst Andrew Steinerman lowered his price target for Equifax shares to $135 from $167 but keeps an Overweight rating on the name after hosting investor meetings with management. It is too early to accurately forecast the security breach's full impact on the company's operations and bottom line, Steinerman tells investors in a research note. He believes attempts to benchmark the event against other large scale breaches are challenging given the unique nature of Equifax's incident. Steinerman, however, says he now feels better about his estimate of a 10% earnings drag in 2018. His conviction in Equifax's long-term outlook "remains strong." The analyst admits, though, that the Congressional hearings bear risk.
09/14/17
SPHN
09/14/17
NO CHANGE
Target $110
SPHN
Equal Weight
Stephens says Equifax not a buy yet, lowers target to $110
Stephens analyst Brett Huff attributes several factors to the additional slide in Equifax shares yesterday, including the fact that 11.5M consumers as of Tuesday have signed up for free monitoring, the implied potential revenue and profit impact from this, and questions about how big lawsuits and other one-time costs could be. Huff, who thinks these one-time costs could be billions of dollars at the high end, would still not be a buyer of the stock despite its about 30% drop since the breach disclosure. He lowered his price target on Equifax shares to $110 from $145 and keeps an Equal Weight rating on the stock. Equifax shares closed yesterday down about 14.5% at $98.99.
09/14/17
LEHM
09/14/17
NO CHANGE
Target $115
LEHM
Overweight
Barclays cuts Equifax target, says further downside 'feels limited'
Barclays analyst Manav Patnaik lowered his price target for Equifax (EFX) shares to $115 but keeps an Overweight rating on the name. The stock closed yesterday down 15%, or $16.91, to $98.99. The analyst lowered his valuation multiple for the stock saying there are few, if any, positive catalysts over the near term as investors continue to digest the data breach. Patnaik, however, believes downside in the stock from current levels "feels limited." Regarding TransUnion (TRU), the analyst raised his price target for the shares to $50 from $48 and says he's a buyer on any further weakness. By all indications, the hack was an Equifax-specific event, Patnaik tells investors in a research note. After meeting with management, he believes TransUnion's fundamentals remain "very strong." The analyst maintains an Overweight rating on the shares.
09/12/17
BARD
09/12/17
NO CHANGE
Target $141
BARD
Outperform
Equifax pullback on data breach an overreaction, says Baird
Baird analyst Jeffrey Meuler said although the Equifax data breach remains a notable negative, he views the selloff as an overreaction. He continues to believe the company's access to key data sources are unlikely to be affected and client relationships are unlikely to be meaningfully impaired in the intermediate to long-term. Meuler reiterated his Outperform rating and $141 price target on Equifax shares.
AAPL Apple
$159.65

-1.21 (-0.75%)

09/14/17
BERN
09/14/17
NO CHANGE
BERN
A.I. 'moving to the edge,' no material impact yet, says Bernstein
Bernstein analyst Pierre Ferragu notes that Apple has announced the much-leaked iPhone X, 8 and 8 plus, and provided additional details provided about the iPhone X's new chip, the A11. While the chip is confirming that A.I. is moving to the edge with applications heavy on pictures and video, it does not have a material impact on leading edge silicon content yet, he argues. The analyst points out that the A11 counts only 30% more transistors than the A10.
09/14/17
MAXM
09/14/17
NO CHANGE
MAXM
Apple fiscal 2018 EPS estimate raised at Maxim
After Apple announced that it would charge $1,000 for its iPhone X, Maxim analyst Nehal Chokshi increased his fiscal 2018 EPS estimate for the company to $13+ from $11.75. According to the analyst, the consensus estimate is roughly $11. However, the analyst lowered his fiscal 2018 iPhone unit sales estimate for Greater China by 25% and cut his fiscal 2018 iPhone unit sales estimate outside of Greater China by 8%. He raised his price target on the stock to $182 from $180 and keeps a Buy rating on the shares.
09/14/17
KEYB
09/14/17
NO CHANGE
KEYB
Lack of Band 71 inclusion a near-term negative for T-Mobile, says KeyBanc
KeyBanc analyst Brandon Nispel says that the lack of inclusion of band 71, or 600 MHz spectrum, in iconic device launches from Samsung (SSNLF) and Apple (AAPL) is a clear negative for T-Mobile (TMUS). T-Mobile spent $8B to purchase this spectrum and will spend more capital going forward to build it out, without having the ability to put it to use for at least another year, he notes. Nispel believes investors are likely to view this as negative, and it could cause some weakness to shares.
09/13/17
HDLY
09/13/17
NO CHANGE
Target $182
HDLY
Long-Term Buy
Apple price target raised to $182 after launch event at Hilliard Lyons
Hilliard Lyons analyst Stephen Turner said that iPhone X will retail starting at $999, in line with his expectations, and will launch November 3, a few weeks later than he'd forecast, but he noted that Apple maintained its Q4 guidance and made clear that it excludes iPhone X sales. Following the event, he increased our price target on Apple to $182 from $180 and keeps a Long-term Buy rating on the stock.

TODAY'S FREE FLY STORIES

CELC

Celcuity

20:34
09/19/17
09/19
20:34
09/19/17
20:34
Syndicate
Celcuity 2.4M share IPO priced at $9.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

BSTI

BEST Inc

20:33
09/19/17
09/19
20:33
09/19/17
20:33
Syndicate
Best Inc 45M share IPO priced at $10.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GIS

General Mills

$55.38

-1.05 (-1.86%)

20:25
09/19/17
09/19
20:25
09/19/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

PCRX

Pacira

$35.70

-0.6 (-1.65%)

20:00
09/19/17
09/19
20:00
09/19/17
20:00
Recommendations
Pacira analyst commentary at BMO Capital »

Pacira's Exparel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AVEVF

Aveva

19:56
09/19/17
09/19
19:56
09/19/17
19:56
Upgrade
Aveva rating change at Goldman Sachs »

Aveva upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZLAB

Zai Lab

18:58
09/19/17
09/19
18:58
09/19/17
18:58
Syndicate
Zai Lab announces upsizing of U.S. IPO of American depositary shares »

Zai Lab announces its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

OHI

Omega Healthcare

$32.53

-0.12 (-0.37%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Hot Stocks
Omega Healthcare provides hurricane update »

Omega Healthcare provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

F

Ford

$11.72

0.09 (0.77%)

18:30
09/19/17
09/19
18:30
09/19/17
18:30
Periodicals
Ford to slash production at five North American assembly plants, Reuters says »

Ford announced it intends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 26

    Oct

FDX

FedEx

$216.00

0.92 (0.43%)

18:26
09/19/17
09/19
18:26
09/19/17
18:26
Hot Stocks
FedEx says without cyberattack FY18 guidance would not have changed »

Comments are from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

EE

El Paso Electric

$54.85

0.05 (0.09%)

18:25
09/19/17
09/19
18:25
09/19/17
18:25
Hot Stocks
El Paso Electric announces City of El Paso approved settlement terms »

El Paso Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

18:17
09/19/17
09/19
18:17
09/19/17
18:17
Hot Stocks
Bed Bath & Beyond says biggest component in drop of FY17 EPS view is operations »

Company dropped its FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CPRT

Copart

$32.54

-0.32 (-0.97%)

18:11
09/19/17
09/19
18:11
09/19/17
18:11
Earnings
Copart reports Q4 EPS 30c, consensus 29c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

STLD

Steel Dynamics

$33.83

0.03 (0.09%)

18:04
09/19/17
09/19
18:04
09/19/17
18:04
Earnings
Steel Dynamics sees Q3 adjusted EPS 63c-67c, consensus 70c »

Steel Dynamics provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBKS

Xenith Bankshares

$29.96

0.42 (1.42%)

17:58
09/19/17
09/19
17:58
09/19/17
17:58
Hot Stocks
Treasury exits stake in Xenith Bankshares »

Xenith Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$62.93

0.23 (0.37%)

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Periodicals
Breaking Periodicals news story on Bristol-Myers »

Times:NHS will supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 26

    Oct

  • 09

    Nov

  • 05

    Mar

BBBY

Bed Bath & Beyond

17:54
09/19/17
09/19
17:54
09/19/17
17:54
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

DESP

Despegar.com

17:52
09/19/17
09/19
17:52
09/19/17
17:52
Syndicate
Despegar.com 12.7M share IPO priced at $26.00 »

The IPO priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

WAC

Walter Investment

$0.65

0.186 (40.09%)

17:50
09/19/17
09/19
17:50
09/19/17
17:50
Hot Stocks
Walter Investment says Barclays to increase financing available »

On September 13, Walter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

17:49
09/19/17
09/19
17:49
09/19/17
17:49
Initiation
CymaBay initiated at Cantor »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

BBBY

Bed Bath & Beyond

17:46
09/19/17
09/19
17:46
09/19/17
17:46
Hot Stocks
Bed Bath & Beyond sees net drop in Bed Bath & Beyond stores in FY17 »

Says rate of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

EVH

Evolent Health

$15.65

-0.8 (-4.86%)

17:45
09/19/17
09/19
17:45
09/19/17
17:45
Initiation
Evolent Health initiated at KeyBanc »

Evolent Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BPL

Buckeye Partners

$56.33

0.64 (1.15%)

17:44
09/19/17
09/19
17:44
09/19/17
17:44
Syndicate
Buckeye Partners announces $210M in limited partnership unit sales »

Buckeye Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$91.03

0.87 (0.96%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
Ralph Lauren initiated at Barclays »

Ralph Lauren initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

PVH

PVH Corp.

$127.47

-0.54 (-0.42%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Initiation
PVH Corp. initiated at Barclays »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

, ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

17:43
09/19/17
09/19
17:43
09/19/17
17:43
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Gemphire…

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

ORIG

Ocean Rig UDW

$0.16

-0.0083 (-4.90%)

IOVA

Iovance Biotherapeutics

$8.55

0.3 (3.64%)

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

FDX

FedEx

$216.00

0.92 (0.43%)

ADBE

Adobe

$156.60

0.83 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 21

    Sep

  • 25

    Sep

  • 25

    Sep

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.